ALT
Altimmune Inc
3.40$
+4.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -110.0% | – | – | – | – | – | – | – | – | |
| – | -5.6% | +1.3% | -3.1% | +117.5% | +28.1% | -23.0% | +84.9% | -10.5% | -3.2% | -50.1% | -52.9% | |
| – | -63.0% | +265.4% | -35.6% | -46.4% | +63.5% | +103.8% | +114.2% | +46.8% | +31.3% | +35.3% | +11.7% | |
| – | -74.9% | +915.8% | +958.7% | -43.9% | -55.2% | +116.1% | -1.4% | -55.7% | – | – | – | |
| – | -1,218.3% | – | -369.2% | – | -73.9% | -348.0% | – | – | -158.6% | – | +50.8% | |
| – | -6.2% | -64.5% | +442.0% | +510.6% | -97.1% | +1,080.8% | +3,495.6% | -99.0% | -62.7% | -100.0% | – | |
| – | -6.4% | +84,654.9% | – | -107.3% | +2,725.4% | +154.9% | – | -183.9% | – | -306.7% | +366.7% | |
| – | – | – | – | – | +16,558,049.2% | -96.4% | – | – | – | – | – | |
| – | -94.8% | +290.7% | +242.9% | -118.3% | – | -96.4% | +65.7% | -100.2% | – | +39.5% | -3.0% | |
| – | -64.1% | -89.3% | – | -155.2% | -81.2% | – | – | – | – | – | – | |
| – | -98.7% | +1,603.5% | +316.8% | +105.1% | -61.4% | +1,603.5% | -69.5% | -12.8% | +51.6% | -88.3% | +1,959.4% | |
| – | -137.7% | – | -93.2% | +133.9% | -215.0% | – | -30.5% | -206.5% | – | -508.7% | – | |
| – | – | – | -110.1% | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.